<DOC>
	<DOCNO>NCT01981954</DOCNO>
	<brief_summary>In child severe form spina bifida ( consequence spinal cord defect ) happen bladder muscle ( detrusor ) contract strongly without warn ( neurogenic detrusor overactivity ) urethra ( passage connect bladder outside ) relax . Those child void urine leakage happen pressure bladder high overcomes close urethra ( overflow high fill bladder pressure ) and/or overactive contraction strong . The high bladder pressure overflow occur put child risk kidney damage overactive contraction decrease quality bladder additionally fact cause leakage . Therapy aim decrease high fill bladder pressure overactive detrusor contraction . The purpose study evaluate long term efficacy safety treatment solifenacin succinate ( study drug ) blood level solifenacin succinate ( study drug ) child neurogenic detrusor overactivity multiple dose administration .</brief_summary>
	<brief_title>A Clinical Study Investigate How Solifenacin Fluid Taken , How Long Stays Body How Effective Safe Treating Children Aged From 6 Months Less Than 5 Years With Symptoms Neurogenic Detrusor Overactivity ( NDO )</brief_title>
	<detailed_description />
	<mesh_term>Solifenacin Succinate</mesh_term>
	<criteria>Myelomeningocoele Documented diagnosis NDO , confirm urodynamics DSD ( detrusor sphincter dyssynergia ) Practicing clean intermittent catheterization ( CIC ) Know genitourinary condition ( NDO ) may cause incontinence Bladder augmentation surgery Current faecal impaction Electrostimulation therapy within 2 week prior visit Subjects follow gastrointestinal problem : partial complete obstruction , decrease motility like paralytic ileus , subject risk gastric retention Reflux grade 3 5 Current urinary tract infection</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>4 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Solifenacin succinate suspension</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Safety</keyword>
</DOC>